The global synthetic-biology market reached nearly $3.9 billion in 2016 and should reach $11.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 24.0% through 2021.
STUDY GOALS AND OBJECTIVES
It’s goal for this study is to determine the specific applications and forecast global market demand for synthetic-biology products over a five-year period from 2016 through 2021. Our particular interest is to characterize and quantify the synthetic-biology-product market potential by product type and end-use market segments. We also analyze the synthetic-biology industry structure, competitors and intellectual property landscape.
Synthetic-biology markets reviewed in this report include enabling products, biologic components, integrated systems and enabled products.
Our key objective is to present a comprehensive analysis of the current and future synthetic-biology industry, with an emphasis on products and technologies that are commercially important in the 2016 through 2021 period. Market segments with rapid growth rates are highlighted, as well as those segments with large market potential. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation and how to compete in the synthetic-biology industry.
The study will be particularly useful to companies supplying synthetic genes and DNA constructs, oligonucleotides, DNA-sequencing products, bioinformatics, cell culture media, biofuels, specialty chemicals, cosmetics, flavors and fragrances, pharmaceuticals, vaccines, agricultural seeds, pest-control systems, microfluidics and life sciences tools.
REASONS FOR DOING THE STUDY
Synthetic biology has established itself as an important discipline within the life sciences industry. While there is enormous potential for future applications, synthetic biology also has a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. Applications include specialty chemicals, enzymes, synthetic genes and cells, as well as pharmaceuticals, agricultural seeds, vaccines, biofuels and chassis microorganisms.
It is important for companies in industries impacted by synthetic biology to be able to sort through the many potential applications, to identify commercial opportunities for product development and competitive strategy. This report provides pertinent information to assist companies in prioritizing product opportunities and establishing a solid framework for strategic planning.
Synthetic biology affects a range of end-user industries including life science research, pharmaceuticals, energy, chemicals and agriculture. Because of its wide scope, synthetic biology plays an important role in the world’s future industrial economy. Continuing advances in enabling technologies such as DNA synthesis and sequencing, specialty media, genome editing and bioinformatics, as well as a need for more efficient microbial production processes, are driving the growth of the synthetic-biology market. Developments in these multidisciplinary fields promise to advance the synthetic-biology industry and create unique market opportunities. This report analyzes these trends and their impact on the future markets for synthetic-biology products.
Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic-biology markets.
CONTRIBUTION OF THE STUDY AND FOR WHOM
We have compiled a study of existing and future synthetic-biology products and technologies that will be commercially important in the main end-user segments of life science research, pharmaceuticals, energy, chemicals and agriculture. We present markets by end-user segment (research, pharmaceuticals, energy, chemicals and agriculture) and by product type (enabling products, biologic components, integrated systems and enabled products). Key market segments are covered, including genome editing, synthetic DNA, DNA sequencing, chassis organisms, synthetic cells, production systems, pharmaceuticals, biofuels, chemicals and agriculture.
We analyze synthetic-biology technologies, growth-driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential and product sales forecasts for the period 2016 through 2021. We project the future use of synthetic-biology products in the main end-user segments and by product type.
This report will be of particular interest to companies in the industries of pharmaceuticals, chemicals, enzymes, energy, agriculture, bioinformatics, biotechnology and nanobiotechnology, as well as suppliers of genomics tools, genome-editing technologies and DNA-synthesis and DNA-sequencing products. It will also be of high interest to professionals within governments and regulatory agencies to understand the scope and pace of synthetic-biology technologies as they reach the market.
SCOPE AND FORMAT
The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years.
We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces.
It examines the synthetic-biology industry by market segment, including the following segments: DNA sequencing; DNA synthesis; genome editing; synthetic-biology foundries; industrial biotechnology; pharmaceuticals; and agriculture. The role of key strategic alliances and acquisitions from 2014 through 2016 is discussed. Emerging markets including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops, chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 135 companies in these fields are highlighted.
It surveys key users and producers in each of the end-user market segments and technology fields that will be commercially important during the next five years. Discussions with industry thought leaders as well as secondary market research were performed.
Based on our analysis, we project the future applications of synthetic-biology technologies in the major end-user market segments and by technology type, and we forecast sales revenues for 2016 through 2021.
It performed primary and secondary research for this report. Primary sources included key industry companies and leading research institutions. In addition, data were compiled from secondary sources, including company websites and industry, trade and government publications.
Table of Contents
4. Synthetic-biology Technologies
5. Synthetic-biology Applications
6. Synthetic-biology Industry
7. Synthetic-biology Markets
9. Company Profiles
For More Related Reports: Biotechnology Market Research Reports
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Our Blog: https://www.bharatbook.com/blog/
Follow us on Facebook: https://www.facebook.com/BharatBook3B
Follow us on Twitter: https://twitter.com/researchbook
Follow us on Linked In: http://www.linkedin.com/company/bharat-book-bureau
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.